While molecular profiling offers many benefits, it also has limitations. Not all cancers have well-defined molecular targets, and the presence of a molecular alteration does not always guarantee that a targeted therapy will work. Additionally, the cost and availability of advanced profiling technologies can be barriers for some patients.
